Overview CART19 Cells Effects in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Status: Recruiting Trial end date: 2028-06-01 Target enrollment: Participant gender: Summary Phase I Dose Escalation Study of CART19 Cells for Adult Patients With Relapsed / Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma. Phase: Phase 1 Details Lead Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic